v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash Flows from Operating Activities              
Net change in net assets resulting from operations $ (21,158,506) $ 155,636,060 $ 7,417,093 $ (806,715) $ 115,773,881 $ 68,938,448  
Adjustments to reconcile net change in net assets resulting from operations to net cash (used in)/provided by operating activities:              
Net realized loss/(gain) on investments 7,748,545 (890,513) (5,196,799) 17,951 1,808,512 (26,391,459)  
Net change in unrealized (appreciation)/depreciation of investments 9,378,815 (158,724,039) (5,675,109) (2,888,878) (148,946,715) (53,401,606)  
Stock-based compensation         11,684,744 691,884  
Amortization of discount on 6.00% Notes due 2026         164,857 183,284  
Amortization of discount on 6.50% Convertible Notes due 2029         163,424 177,823  
Amortization of discount on 6.50% Redeemable Promissory Note due 2029 [1]         7,583  
Write-off of deferred offering costs         564,848  
Adjustments to escrow proceeds receivable         (124,351) (45,299)  
Purchases of investments in:              
Portfolio investments         (30,017,065) (12,042,954)  
U.S. Treasury bills         (24,995,139)  
Proceeds from sales or maturity of investments in:              
Portfolio investments         25,594,714 49,066,513  
U.S. Treasury bills         24,995,139  
Accounts payable and accrued expenses         739,281 2,084,950  
Interest and dividends receivable         106,604 645,013  
Escrow proceeds receivable         45,298  
Prepaid expenses and other assets         (29,420) (34,487)  
Accrued management fees [1]         622,264  
Accrued interest payable [1]         270,833  
Net Cash (Used in)/Provided by Operating Activities         (21,616,006) 29,917,408  
Cash Flows from Financing Activities              
Proceeds from the issuance of common stock, net         10,556,637  
Gross proceeds from the issuance of 6.50% Redeemable Promissory Note due 2029 [1]         20,000,000  
Gross proceeds from the issuance of 6.50% Convertible Notes due 2029         5,000,000  
Deferred debt issuance costs [1]         (109,354) (158,157)  
Repurchases of 6.00% Notes due 2026         (49,528) (4,954,950)  
Realized loss on partial repurchase of 6.00% Notes due 2026         11 15,875  
Deferred financing costs         (245,461) (26,908)  
Cash dividends paid         (301,291) (5,797,748)  
Cash paid for fractional shares         (33)  
Shares repurchased for tax withholdings on vesting of employee equity awards         (5,897,743)  
Net Cash Provided by Financing Activities         13,396,601 4,634,749  
Total (Decrease)/Increase in Cash Balance         (8,219,405) 34,552,157  
Cash and Restricted Cash Balance at Beginning of Year [2]   $ 49,072,895   $ 20,035,640 49,072,895 20,035,640 $ 20,035,640
Cash and Restricted Cash Balance at End of Period [2] $ 40,853,490   $ 54,587,797   40,853,490 54,587,797 $ 49,072,895
Supplemental Information:              
Interest paid         3,124,877 3,477,753  
Taxes paid         35,505 (215,949)  
Right of use asset obtained in exchange for operating lease liabilities         (2,006)  
Conversion of 6.50% Convertible Notes due 2029         $ 8,000,000  
[1] All or a portion of this balance references a related-party transaction. Refer to “Note 3—Related-Party Arrangements” for more detail.
[2] Refer to the Condensed Consolidated Statements of Assets and Liabilities for additional detail.